logo

For the Inventor, By the Inventor

Frederick, PA, United States of America

William A Bolhofer

This inventor holds 15 USPTO granted patents, primarily in Gastric Secretion Inhibitors. Top assignee: Merck + Co., Inc.. Active years: 1976-1986.

IDiyas Innovation Intelligence. (2026). Inventor Profile: William A Bolhofer. Retrieved from https://idiyas.com/inventor/william-a-bolhofer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 15

% Patents Active = 100.0

Average Co-Inventor Count = 1.6

ph-index = 6

Forward Citations = 174(Granted Patents)


Company Filing History:

goldMedal15 out of 4,770 
 
Merck + Co., Inc.
 patents

Years Active: 1976-1986

Loading Chart...
Areas of Expertise:
Amino-Phenyl-Thiadiazoledioxides
Pyridine Derivatives
Gastric Acid Secretion
Imidazole
Substituted Ureas
Heterocyclic Carbamates
Pyrimidylcarbamates
Naphthyridinones
Cyclic Imidazole
Pyrazine
Pharmaceutical Use
N-Dialkylaminoalkyl Ureas
15 patents (USPTO):Explore Patents
1. 4567191 - Amino-phenyl-thiadiazoledioxides as gastric secretion inhibitors (1986-01-28),
2. 4490533 - Aminoalkyl pyridine derivatives (1984-12-25),
3. 4420615 - Substituted pyridopyrimidines as gastric secretion inhibitors (1983-12-13),
4. 4415575 - Suppression of gastric acid secretion using pyrimidylcarbamates (1983-11-15),
5. 4293703 - Imidazole or imidazoline substituted ureas (1981-10-06),
6. 4241072 - Substituted ureas and processes for their preparation (1980-12-23),
7. 4229456 - Substituted naphthyridinones and processes for their preparations (1980-10-21),
8. 4226871 - Heterocyclic carbamates (1980-10-07),
9. 4220654 - Cyclic imidazole cyanoguanidines (1980-09-02),
10. 4215121 - Pyrazine substituted ureas (1980-07-29),
11. 4203988 - Pyridinyl ureas and pharmaceutical use (1980-05-20),
12. 4144338 - N-pyrimidinyl-N-dialkylaminoalkyl ureas (1979-03-13),
13. 4133885 - Substituted naphthyridinones (1979-01-09),
14. 4055592 - N-(Sulfo-lower alkyl) amides of (3-trifluoromethylphenoxy) (1977-10-25),
15. 3953465 - 2-[.alpha.-(3-Trifluoromethylphenoxyl)-4-chlorobenzyl]oxazole and (1976-04-27),

Title: William A. Bolhofer: Innovator in Gastric Health

Introduction

William A. Bolhofer is an accomplished inventor based in Frederick, PA, known for his significant contributions to the field of medical science. With a remarkable portfolio of 15 patents, Bolhofer has made strides in developing innovative compounds aimed at improving gastric health in mammals.

Latest Patents

His latest patents include groundbreaking work on amino-phenyl-thiadiazoledioxides, which serve as gastric secretion inhibitors. This novel class of compounds provides a mechanism to suppress gastric acid secretions effectively. Additionally, he has patented aminoalkyl pyridine derivatives, which also focus on the suppression of gastric acid secretions, demonstrating a strong commitment to advancing therapeutic options in this area.

Career Highlights

William A. Bolhofer works with Merck & Company, Inc., a globally recognized leader in pharmaceutical innovation. Throughout his career, he has focused on enhancing treatment methodologies for gastric-related ailments, contributing to the body of knowledge with his extensive research and patent work.

Collaborations

In his professional journey, Bolhofer has collaborated with notable peers, including Jacob M. Hoffman, Jr. and Edward J. Cragoe, Jr. These partnerships have allowed him to engage in multidisciplinary approaches to problem-solving within the pharmaceutical sector, further enriching his research contributions.

Conclusion

William A. Bolhofer stands out as a significant figure in the realm of medical inventions, particularly relating to gastric health. His patents not only reflect a deep understanding of medicinal chemistry but also underscore his commitment to advancing healthcare solutions for better patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…